Converging evidence of blood-based biomarkers for schizophrenia: an update.

Int Rev Neurobiol 2011 ;101:95-144

Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.

This chapter has carried out a review of the literature and combined this with the results of in-house studies to identify candidate blood-based biomarkers for schizophrenia and antipsychotic drug response. Literature searches retrieved 185 publications describing a total of 273 schizophrenia biomarkers identified in serum and/or plasma. Examination of seven in-house multicenter studies resulted in the identification of 137 serum/plasma biomarkers. Taken together, the findings suggested an ongoing immunological and inflammatory process in schizophrenia. This was accompanied by altered cortisol levels which suggested activated stress response and altered hypothalamic-pituitary-adrenal axis function in these patients. The authors conclude that such biomarkers may prove useful as additional parameters for characterizing specific immune and/or metabolic or hormonal subsystems in schizophrenia and might, therefore, facilitate the development of future patient stratification and personalized medicine strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-387718-5.00005-5DOI Listing
August 2012

Publication Analysis

Top Keywords

blood-based biomarkers
8
biomarkers schizophrenia
8
schizophrenia
5
biomarkers
5
altered cortisol
4
accompanied altered
4
schizophrenia accompanied
4
process schizophrenia
4
inflammatory process
4
cortisol levels
4
suggested activated
4
activated stress
4
response altered
4
immunological inflammatory
4
stress response
4
levels suggested
4
findings suggested
4
in-house multicenter
4
multicenter studies
4
examination in-house
4

Similar Publications